Structured SMBG in early management of T2DM: Contributions from the St Carlos study

Gracia, Teresa Ruiz; Lobo, N. García de la Torre; Hervada, Alejandra Durán Rodríguez; Pascual, Alfonso Luis Calle

doi:10.4239/wjd.v5.i4.471

Cited by 9 publications

(6 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, under our study conditions, achievement of HbA1c target values together with type of hyperglycemia treatment was apparently the main drivers for SMBG-strips usage. Regarding these results, other authors have reported that SMBG aids physicians and patients to achieve target glycemic control levels that prevent the development of acute and chronic complications [21,22]. These results could be partly ascribed to the fact that high frequency of SMBG has been associated with earlier and more frequent changes in the clinician's prescription of diabetes medication [23][24][25].…”

Section: Discussionmentioning

confidence: 96%

Frequency of self-monitoring blood glucose and attainment of HbA1c target values

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 96%

Frequency of self-monitoring blood glucose and attainment of HbA1c target values

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Nowadays, for most patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) globally, self-monitored blood glucose (SMBG) has become an essential component of modern diabetic therapy to achieve the target level of glycemic control and to prevent hypoglycemia [ 12 ]. However, SMBG just gives snapshots of blood glucose concentrations.…”

Section: Introductionmentioning

confidence: 99%

Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study

et al. 2022

View full text Add to dashboard Cite

Introduction Hemoglobin A1C (HbA1c) is an important marker for diabetes care management. With the increasing use of new technologies such as continuous glucose monitoring (CGM) and point-of-care testing (POCT), patients and their physicians have been able to monitor and continuously check their blood glucose levels in an efficient and timely manner. This study aimed to investigate the level of agreement between the standard laboratory test for HbA1c (Lab-HbA1c) with point-of-care testing (POCT-HbA1c) and glucose monitoring index (GMI) derived by intermittently scanned CGM (isCGM) or estimated average glucose (eAG) derived by conventional self-monitored blood glucose (SMBG) devices. Methods A cross-sectional study was conducted at the Diabetes Treatment Center, Prince Sultan Military Medical City, Saudi Arabia, between May and December 2020 with 81 patients with diabetes who used the isCGM system ( n = 30) or conventional finger-pricking SMBG system ( n = 51). At the same visit, venous and capillary blood samples were taken for routine HbA1c analysis by the standard laboratory and POCT methods, respectively. Also, for isCGM users, the GMI data for 28 days (GMI-28) and 90 days (GMI-90) were obtained, while for SMBG users, eAG data for 30 days (eAG-30) and 90 days (eAG-90) were calculated. The limits of agreement in different HbA1c measurements were evaluated using a Bland-Altman analysis. Pearson correlation and multivariate linear regression analyses were also performed. Results Based on the Bland-Altman analysis, HbA1c levels for 96.7% and 96.1% of the patients analyzed by the POCT and the standard laboratory methods were within the range of the 95% limit of agreement in both isCGM and conventional SMBG users, respectively. About 93.3% of the GMI measurements were within the 95% limit of agreement. Also, about 94.12% of the eAG-30 and 90.2% of the eAG-90 measurements were within the 95% limit of agreement. Moreover, the correlation analysis revealed a statistically significant positive correlation and linear regression among Lab-HbA1c, POCT-HbA1c, GMI, and eAG in both conventional SMBG and isCGM users (all p < 0.001). These positive results persisted significantly after adjusting for different factors (all p < 0.001). Conclusion GMI derived by isCGM or eAG derived by conventional SMBG systems, as well as the POCT-HbA1c measurements, showed a high level of agreement; therefore, we recommend them as potential methods for diabetes monitoring, especially when a rapid result is needed or with patients with uncontrolled diabetes or on intensive insulin therapy.

show abstract

“…Despite the evidence that the self-monitoring of BG (SMBG) and a healthy lifestyle are beneficial for controlling the disease, the implementation of effective SMBG and long-term lifestyle changes is a huge daily challenge [ 6 ]. The disadvantages of SMBG are related mainly to individual patients, who may lack the motivation for testing or may not be sufficiently aware of how/when to test and how to interpret the results [ 7 ].…”

Section: Introductionmentioning

confidence: 99%

Telemedicine-assisted structured self-monitoring of blood glucose in management of T2DM results of a randomized clinical trial

Han,

Zhang,

et al. 2023

BMC Med Inform Decis Mak

View full text Add to dashboard Cite

Background This prospective study aimed to compare telemedicine-assisted structured self-monitoring of blood glucose(SMBG) with a traditional blood glucose meter (BGM) in adults of type 2 diabetes mellitus (T2DM). Methods Adult participants with T2DM were assigned to an intervention group or a control group. The patients in the intervention group received a connected BGM with real-time data submission as well as individual needs-based tele-coaching to address and improve motivation and daily diabetes self-management. The patients in the control group received a traditional BGM. Changes in glycated hemoglobin(HbA1c), low blood glucose index(LBGI), and diabetes self-management behaviors were analyzed. Results The study demonstrated the superiority of the telemedicine-assisted structured SMBG versus the traditional BGM for improving HbA1c. Additionally, the telemedicine-assisted SMBG reduced the risk of hypoglycemia and enhanced diabetes self-management behaviors, as differences in the LBGI and the Diabetes Self-Management Questionnaire(DSMQ) results between the groups after 6 months were found to be significant. Conclusions Telemedicine-assisted structured SMBG helps physicians and patients to achieve a specific level of glycemic control and reduce hypoglycemia. The use of coaching applications and telemedicine-assisted SMBG indicated beneficial effects for T2DM self-management, which may help limit disease progression. Trial registration Chinese Clinical Trail Registry No: ChiCTR2300072356 on 12/06/2023. Retrospectively registered.

show abstract

Structured SMBG in early management of T2DM: Contributions from the St Carlos study

Cited by 9 publications

References 30 publications

Frequency of self-monitoring blood glucose and attainment of HbA1c target values

Frequency of self-monitoring blood glucose and attainment of HbA1c target values

Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study

Telemedicine-assisted structured self-monitoring of blood glucose in management of T2DM results of a randomized clinical trial

Contact Info

Product

Resources

About